Indian shares rally for seventh day; Lupin gains on regulatory nod

Asian shares rose, shrugging off modest losses on Wall Street. MSCI's broadest index of Asia-Pacific shares outside Japan was up 0.5 percent.

india trader
Reuters

Indian shares continued their winning streak to day seven on Tuesday, tracking gains in Asian equities amidst global growth optimism.

Asian shares rose, shrugging off modest losses on Wall Street. MSCI's broadest index of Asia-Pacific shares outside Japan was up 0.5 percent.

Japan's Nikkei stock index reversed early losses and gained 0.4 percent, as markets reopened after a public holiday on Monday. Seoul markets were closed last week and on Monday for public holidays.

At 0605 GMT, the S&P BSE Sensex gained 0.37 percent at 31,965 while the broader NSE Nifty gained 0.33 percent to 10,022.

Among the top Sensex gainers: Lupin rose 2.2 percent, Reliance Industries added 1.7 percent, Infosys gained 1.3 percent while Power Grid advanced 1 percent.

Shares of Suven Life Sciences jumped 6 percent after the company announced that it received a product patent from New Zealand.

Adani Transmission hit 10 percent upper circuit after the company said it is in pact with Reliance Infra for acquiring its Mumbai operations. Reliance Infra shares were up 2 percent.

Lupin was amongst the top gainers after the company said it got U.S. FDA approval for a generic hypertension drug Corgard, which has a market size of $109 million.

Among the laggards, Tata Teleservices Maharashtra slumped 13 percent. The stock fell for second session after news report said that the company will shut down its operations.

Market breadth was in the favour of gainers, with about 2 stocks advancing to every 1 stock that declined.

READ MORE